Global Point-of-Care Diagnostics Market Size Set to Reach USD 114.65 Billion by 2035 – SNS Insider
Advancements in biosensors, microfluidics, and AI-driven diagnostics accelerate adoption across hospitals and home care, with strong U.S. and Asia-Pacific growth momentum.
Austin, United States, April 30, 2026 (GLOBE NEWSWIRE) — The global Point-of-Care (POC) Diagnostics Market was valued at USD 54.50 billion in 2025 and is projected to reach USD 114.65 billion by 2035, expanding at a CAGR of 7.72% during 2026–2035. The market is largely driven by the increasing demand for speedy accurate and point-of-care diagnostic methods.
In point-of-care testing, a sample is gathered and tested at or near the location where the patient is receiving care, drastically reducing the time it takes to try them using a centralized laboratory system. Their performance is being improved through continuing research into aspects such as biosensors, microfluidic chips and AI-driven analysis.
Point-of-Care Diagnostics Market Size & Forecast
- Market Size (2025): USD 54.50 Billion
- Projected Market Size (2035): USD 114.65 Billion
- CAGR (2026–2035): 7.72%
- Forecast Period: 2026–2035
- Base Year: 2025
Get a Sample Report of Point-of-Care Diagnostics Market: https://www.snsinsider.com/sample-request/5572
The U.S. Point-of-Care Diagnostics industry was valued at USD 23.44 Billion in 2025 and it is expected to reach USD 49.30 Billion by 2035, growing at a CAGR of 7.72% during the forecast period of 2025-2035. This dominance is due to the healthcare system and healthcare expenditure in the country and chronic diseases like diabetes and heart diseases.
In addition, regulatory backing, such as CLIA-waived tests and FDA’s regulatory framework, continues to boost the adoption rate of innovative diagnostics. In addition, the growing consumer awareness and demand for home diagnostics drive the growth of the market.
Rising Burden of Chronic and Infectious Diseases
The rising number of cases of chronic diseases such as diabetes, cardiovascular diseases, chronic kidney diseases, and respiratory disorders is one of the major factors driving the growth of this market. As an alternative, infectious diseases like influenza, HIV, tuberculosis, and emerging pathogens also need rapid and they continue to need good diagnostic.
POC diagnostics provide rapid, cost-effective, and accessible testing strategies that are available in last mile clinical and non-clinical settings. Meanwhile, the COVID-19 pandemic only sped the additional spread of and penchant for decentralized testing and provided sustainable, long-term exertion for rapid worldwide diagnostics.
Segment Analysis
By Product: Blood Glucose Monitoring Dominates; Molecular Diagnostics Fastest Growing
Blood glucose monitoring held over 54% of the market share, due to the growing diabetic patient population across the globe, which has now exceeded 537 million adults. The ultra-thin wearable CGM devices that can be used on smartphones are changing the diabetes care landscape. The molecular diagnostics segment is projected to grow at the highest CAGR owing to advancements in isothermal amplification, lab-on-a-chip, and microfluidic technologies.
By Sample Type: Blood Leads; Urine Gains Momentum
Blood-based testing are expected to remain dominant throughout the markets, due to their diagnostic accuracy, and the large scope of their applicability to treatment of various diseases. They are essentiel in the event of emergency and critical situations.
Urine-based diagnostics are expected to grow at the highest CAGR due to their non-invasiveness and precision in use along with rising applications in CKD, UTIs, and metabolic disorder detection.
By End User: Hospitals Lead; Home Care Expands Rapidly
Hospitals occupied the highest market share in 2025 because of the large number of patients, infrastructure development, and need for bedside diagnosis in emergency situations. However, Home care is the fastest growing segment, owing to increased awareness among consumers, availability of self-test kits, and move towards patient-centric healthcare. There has been an increase in demand for at-home testing kits for diabetes, infections, and chronic diseases.
Do you have any specific queries or need any customization research on Point-of-Care Diagnostics Market, make an Enquiry Now: https://www.snsinsider.com/enquiry/5572
Regional Insights
North America dominated the market with more than 43% share in 2025, owing to the presence of robust healthcare infrastructure and high spending on diagnosis and advanced technology. Moreover, the support from companies such as Abbott, Roche, Siemens Healthineers, and, Becton Dickinson also aids the market growth.
The expected growth in the Asia-Pacific region will be robust at approximately 8.97% CAGR. Factors responsible for this include an increase in health expenditure, the rise in hospitals and hospital centres and high incidence of the chronic and communicable disease. For nations like China and India, they need novel and low-cost diagnostic products that are easy to transport.
Major Point-of-Care Diagnostics Market Companies Listed in the Report are
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers
- Danaher Corporation (Cepheid, Radiometer)
- Becton Dickinson and Company
- Thermo Fisher Scientific
- Quidel Corporation (QuidelOrtho)
- bioMérieux SA
- Chembio Diagnostics
- Alere Inc.
- Binax
- OraSure Technologies
- Nova Biomedical
- Mindray Medical International
- i-STAT
- Boehringer Ingelheim
- Nihon Kohden Corporation
- Sekisui Diagnostics
- Polymer Technology Systems
- LumiraDx
Point-of-Care Diagnostics Market Key Segments
By Product
- Blood Glucose Monitoring
- Infectious Disease Monitoring
- Cardiometabolic Disease Testing
- Hematology Testing
- Others
By Sample
- Blood
- Nasal and Oropharyngeal Swabs
- Urine
- Others
By End- User
- Hospital Bedside
- Physican’s Office Lab
- Urgent Care & Retail Clinics
- Home & Self Testing
Buy an Enterprise-User PDF of Point-of-Care Diagnostics Market Outlook Report 2026-2035: https://www.snsinsider.com/checkout/5572
Point-of-Care Diagnostics Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 54.50 Billion |
| Market Size by 2035 | USD 114.65 Billion |
| CAGR | CAGR of 7.72% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Related Market Reports
Point-of-Care Molecular Diagnostics Market
Point-of-Care Ultrasound Market
Point of Care Diagnostics/Testing Market
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315-961-9094 (US) Email: info@snsinsider.com
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaEveningPost.com takes no editorial responsibility for the same.